Targeting the p53 Pathway

被引:28
|
作者
Golubovskaya, Vita M. [1 ,2 ]
Cance, William G. [1 ,2 ,3 ]
机构
[1] Roswell Pk Canc Inst, Dept Surg Oncol, Buffalo, NY 14127 USA
[2] CureFAKtor Pharmaceut, Buffalo, NY USA
[3] SUNY Buffalo, Dept Surg, Buffalo, NY 14260 USA
关键词
p53; Mdm-2; FAK; Survival; Apoptosis; FOCAL-ADHESION KINASE; SMALL-MOLECULE INHIBITOR; MDM-2 ANTAGONIST NUTLIN-3; SQUAMOUS-CELL CARCINOMA; AMINO-TERMINAL DOMAIN; PROLINE-RICH REGION; MUTANT P53; BREAST-CANCER; BINDING-SITE; TUMOR-GROWTH;
D O I
10.1016/j.soc.2013.06.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This article summarizes data on translational studies to target the p53 pathway in cancer. It describes the functions of the p53 and Mdm-2 signaling pathways, and discusses current therapeutic approaches to target p53 pathways, including reactivation of p53. In addition, direct interaction and colocalization of the p53 and focal adhesion kinase proteins in cancer cells have been demonstrated, and different approaches to target this interaction are reviewed. This is a broad review of p53 function as it relates to the diagnosis and treatment of a wide range of cancers.
引用
收藏
页码:747 / +
页数:19
相关论文
共 50 条
  • [1] Targeting the p53 Pathway of Apoptosis
    Amaral, Joana D.
    Xavier, Joana M.
    Steer, Clifford J.
    Rodrigues, Cecilia M. P.
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (22) : 2493 - 2503
  • [2] Combined targeting of the p53 and pRb pathway in neuroblastoma
    Schubert, Nil
    Schild, Linda
    van Oirschot, Stijn
    Keller, Kaylee
    Alles, Lindy
    Vernooij, Lindy
    Nulle, Marloes
    Dolman, Emmy
    van den Boogaard, Marlinde
    Molenaar, Jan
    CANCER RESEARCH, 2020, 80 (14) : 69 - 69
  • [3] Targeting mutant p53 through the mevalonate pathway
    Freed-Pastor, William
    Prives, Carol
    NATURE CELL BIOLOGY, 2016, 18 (11) : 1122 - 1124
  • [4] Strategies for therapeutic targeting of the p53 pathway in cancer
    Wiman, K. G.
    CELL DEATH AND DIFFERENTIATION, 2006, 13 (06): : 921 - 926
  • [5] Strategies for therapeutic targeting of the p53 pathway in cancer
    K G Wiman
    Cell Death & Differentiation, 2006, 13 : 921 - 926
  • [6] Targeting mutant p53 through the mevalonate pathway
    William Freed-Pastor
    Carol Prives
    Nature Cell Biology, 2016, 18 : 1122 - 1124
  • [7] Targeting p53
    Madrid, LV
    SCIENTIST, 1999, 13 (04): : 14 - 14
  • [8] Therapeutic targeting of the p53 pathway in cancer stem cells
    Prabhu, Varun V.
    Allen, Joshua E.
    Hong, Bo
    Zhang, Shengliang
    Cheng, Hairong
    El-Deiry, Wafik S.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (12) : 1161 - 1174
  • [9] Targeting the p53 Pathway to Protect the Neonatal Ischemic Brain
    Nijboer, Cora H.
    Heijnen, Cobi J.
    van der Kooij, Michael A.
    Zijlstra, Jitske
    van Velthoven, Cindy T. J.
    Culmsee, Carsten
    van Bel, Frank
    Hagberg, Henrik
    Kavelaars, Annemieke
    ANNALS OF NEUROLOGY, 2011, 70 (02) : 255 - 264
  • [10] The P53 pathway
    Prives, C
    Hall, PA
    JOURNAL OF PATHOLOGY, 1999, 187 (01): : 112 - 126